"Body Mass Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)
| Descriptor ID |
D015992
|
| MeSH Number(s) |
E01.370.600.115.100.125 E05.041.124.125 G07.100.100.125 N06.850.505.200.100.175
|
| Concept/Terms |
Body Mass Index- Body Mass Index
- Index, Body Mass
- Quetelet Index
- Index, Quetelet
- Quetelet's Index
- Quetelets Index
|
Below are MeSH descriptors whose meaning is more general than "Body Mass Index".
Below are MeSH descriptors whose meaning is more specific than "Body Mass Index".
This graph shows the total number of publications written about "Body Mass Index" by people in this website by year, and whether "Body Mass Index" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 4 | 6 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 6 | 6 |
| 2015 | 0 | 5 | 5 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 6 | 7 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 4 | 4 |
| 2020 | 1 | 3 | 4 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 4 | 4 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Body Mass Index" by people in Profiles.
-
Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort. Obesity (Silver Spring). 2025 Mar; 33(3):612-620.
-
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics. J Child Adolesc Psychopharmacol. 2024 05; 34(4):201-209.
-
Associations of regular consumption of breakfast, lunch and dinner with Body Mass Index during adolescence: longitudinal findings by weight status among the Eating and Activity over Time 2010-2018 cohort. Public Health Nutr. 2024 Feb 22; 27(1):e95.
-
Correlation between subcutaneous adipose tissue of the head and body mass index in children and young adults aged 8-19 years: implications for functional neuroimaging. Exp Biol Med (Maywood). 2024; 249:10030.
-
Receiving gestational weight gain recommendations and associated risks: A qualitative study among low-income women. Midwifery. 2024 Apr; 131:103939.
-
The Effectiveness of Metformin in Managing Second Generation Antipsychotic-Induced Weight Gain in Children and Adolescents. J Clin Psychiatry. 2023 Dec 20; 85(1).
-
Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation Antipsychotics. J Child Adolesc Psychopharmacol. 2023 09; 33(7):269-278.
-
Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescents. J Psychiatr Res. 2023 09; 165:170-173.
-
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma. Clin Cancer Res. 2023 Jan 04; 29(1):154-164.
-
Correlation between subcutaneous adipose tissue of the head and body mass index: Implications for functional neuroimaging. Hum Mov Sci. 2022 Oct; 85:102997.